Segment Reporting

6 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Segment Reporting

15. Segment Reporting

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated on a regular basis by the chief operating decision-maker ("CODM") in deciding how to allocate resources to an individual segment and in assessing performance of the segment. The Company has concluded that its Chief Executive Officer is the CODM as he is the ultimate decision maker for key operating decisions, determining the allocation of resources and assessing the financial performance of the Company. These decisions, allocations and assessments are performed by the CODM using consolidated financial information. Consolidated financial information is utilized by the CODM as the Company's current product offering primarily consists of minimally invasive therapeutic ultrasonic medical devices and wound care products. The Company's products are relatively consistent and manufacturing is centralized and consistent across product offerings. However, based on the Solsys Acquisition, the Company is currently evaluating its business to conclude as to whether it operates in more than one segment.

Worldwide revenue for the Company's product revenue is categorized as follows:

	For the three months ended				For the six months ended
	December 31				December 31
	2019		2018		2019		2018
Domestic	$	15,258,713	$	6,078,554	$	21,803,621	$	11,487,878
International		4,463,273		4,097,899		9,064,287		8,049,739
Total	$	19,721,986	$	10,176,453	$	30,867,908	$	19,537,617

Substantially all of the Company's long-lived assets are located in the United States.